Inside Abbott’s upcoming clinical trial for treatment-resistant depression
Nine years after cutting a trial short, Abbott is rebooting its efforts to zap treatment-resistant depression.
Nine years after cutting a trial short, Abbott is rebooting its efforts to zap treatment-resistant depression.
Over 1 million people begin menopause each year.
While some of us spent college perfecting the art of the midday nap, these students were perfecting potentially life-changing innovations.
Giving patients a “healthcare home” is the best care for weight management, according to one startup founder.
This is the latest venture in a 10-program deal inked last year between the pharma giant and VC firm.
The three partners plan to invest in up to 12 health tech, medtech, and/or biotech startups.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.